Exicure XCUR 深 滬
等待開盤 09-24 09:30:00 美东时间
1.24
-0.050
-3.88%
華盛通- 最 高1.29
- 今 開1.25
- 成交量 9327股
- 最 低 1.23
- 昨 收 1.29
- 總市值 811.70万
- 52周最高 9.4799
- 市盈率 靜 --
- 換手率 0.14%
- 52周最低 1.05
- 委 比 89.66%
- 總股本 654.60万
- 歷史最高 576.00
- 量 比 0.39
- 振 幅 4.65%
- 歷史最低 1.05
- 每 手 1
- 風險率 1.47%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Exicure gets Nasdaq compliance extension
Exicure (XCUR) received a Nasdaq extension through December 2, 2026 to regain compliance with listing rule. The rule requires Exicure to maintain at least $2.5M in stockholders’ equity. The company al...
09-16 20:49
Exicure Receives Nasdaq Extension to Regain Compliance with Stockholders’ Equity Requirement
Exicure, Inc. received a Nasdaq extension until December 2, 2026, to regain compliance with the $2.5 million stockholders’ equity requirement. The company previously failed to meet this rule on June 5, 2026, and must demonstrate compliance by the new deadline. Nasdaq will monitor progress, including through the next periodic report. Exicure plans to pursue compliance initiatives but faces uncertainty in regaining or maintaining compliance. If uns...
09-16 12:00
凯雷Q2重仓医疗用品巨头Medline(MDLN.US)和航空维修巨头StandardAero(SARO.US) 建仓AI新云厂商Nebius(NBIS.US)
根据美国证券交易委员会(SEC)披露，全球另类资产管理巨头凯雷(CARLYLE GROUP INC)递交了截止至2026年6月30日的第二季度持仓报告(13F)。
08-10 17:18
Exicure Plans To Issue 172,058 Common Shares To GPCR Therapeutics During This Month To Settle $1M Clinical Milestone Payment Obligation
Exicure, Inc. (NASDAQ:XCUR) ("Exicure" or the "Company") today announced that it expects to issue 172,058 shares of its common stock to GPCR Therapeutics, Inc. ("GPCR Therapeutics") during August 2026 in settlement of a $1.0 million clinical milestone payment obligation under the parties’ License an...
08-03 21:28
Exicure Receives Nasdaq Noncompliance Notice, Gets Time Through July 20 To Regain Compliance
Exicure, Inc. (NASDAQ:XCUR) (the "Company") today announced that it received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") on June 5, 2026 indicating that the Company is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires...
06-11 04:01
Exicure Q1 EPS $(0.29) Down From $0.49 YoY
Exicure (NASDAQ:XCUR) reported quarterly losses of $(0.29) per share. This is a 159.18 percent decrease over earnings of $0.49 per share from the same period last year.
05-30 05:36
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Galmed Pharmaceuticals (NASDAQ:GLMD) stock increased by 83.2% to $1.14...
04-09 20:05
Exicure Reaches Settlement In Shareholder Derivative Lawsuit, Agrees To Governance Reforms And $675K Legal Fee Payment
Exicure, Inc. (NASDAQ:XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today released the following notice:TO: ALL RECORD HOLDERS AND BENEFICIAL OWNERS OF EXICURE, INC.
04-03 04:02
Exicure Q4 EPS $(0.22) Up From $(3.39) YoY.
Exicure (NASDAQ:XCUR) reported quarterly losses of $(0.22) per share. This is a 93.51 percent increase over losses of $(3.39) per share from the same period last year.
03-26 04:35
On Feb 11, The Board Of Directors Of Exicure Appointed Jung Soo Kim As CEO And President; Appointed Gyuyeob Lee As Interim CFO; Andy Yoo Resigns As CEO And President; Seung Ik Baik Resigned As CFO
On February 11, 2026, the board of directors (the "Board") of Exicure, Inc. (the "Company") appointed Jung Soo Kim as the Chief Executive Officer and President of the Company, and also appointed Gyuyeob Lee as the
02-18 06:38
